Total Payments
$1,145
2024 Payments
$217.66
Companies
9
Transactions
23
Medicare Patients
2,832
Medicare Billing
$303,395
Payment Breakdown by Category
Food & Beverage$1,145 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,145 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $227.12 | 3 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $218.28 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $180.73 | 4 | $0 (2024) |
| Mallinckrodt LLC | $120.47 | 1 | $0 (2017) |
| The Medicines Company | $116.16 | 7 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $109.54 | 2 | $0 (2017) |
| CSL Behring | $97.76 | 1 | $0 (2023) |
| Relypsa, Inc. | $63.25 | 1 | $0 (2017) |
| Melinta Therapeutics, Inc. | $12.15 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $217.66 | 4 | AstraZeneca Pharmaceuticals LP ($139.35) |
| 2023 | $147.19 | 2 | CSL Behring ($97.76) |
| 2019 | $12.15 | 1 | Melinta Therapeutics, Inc. ($12.15) |
| 2018 | $202.50 | 3 | AstraZeneca Pharmaceuticals LP ($87.77) |
| 2017 | $565.96 | 13 | E.R. Squibb & Sons, L.L.C. ($156.54) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/14/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $54.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/05/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $122.83 | General |
| Category: Rare Disease | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $16.52 | General |
| Category: Rare Disease | ||||||
| 08/10/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $49.43 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $97.76 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 09/18/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug), Baxdela | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: ANTIBIOTICS | ||||||
| 05/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $52.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $61.74 | General |
| Category: Cardiovascular | ||||||
| 03/08/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $87.77 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/07/2017 | The Medicines Company | ORBACTIV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/03/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/16/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.15 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/09/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Cardiovascular | ||||||
| 06/08/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $63.25 | General |
| Category: Hyperkalemia | ||||||
| 04/12/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $93.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/28/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $0.28 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/08/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $98.05 | General |
| Category: Cardiovascular | ||||||
| 01/11/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $120.47 | General |
| Category: ACUTE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 492 | 507 | $533,775 | $45,942 |
| 2022 | 5 | 769 | 794 | $774,294 | $73,034 |
| 2021 | 5 | 871 | 921 | $919,051 | $92,620 |
| 2020 | 4 | 700 | 737 | $860,871 | $91,799 |
Total Patients
2,832
Total Services
2,959
Medicare Billing
$303,395
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 227 | 235 | $351,450 | $30,324 | 8.6% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 107 | 109 | $110,654 | $9,660 | 8.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 19 | 20 | $37,001 | $3,223 | 8.7% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 37 | 40 | $26,826 | $2,127 | 7.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 102 | 103 | $7,844 | $606.87 | 7.7% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 330 | 342 | $497,464 | $46,760 | 9.4% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 158 | 162 | $157,783 | $15,215 | 9.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 37 | 39 | $69,501 | $6,651 | 9.6% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 57 | 57 | $36,518 | $3,200 | 8.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 187 | 194 | $13,028 | $1,208 | 9.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 409 | 447 | $619,206 | $62,333 | 10.1% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 154 | 158 | $146,408 | $15,134 | 10.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 57 | 57 | $98,396 | $10,196 | 10.4% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 66 | 69 | $42,824 | $3,741 | 8.7% |
| 93010 | Routine electrocardiogram (ekg) using at least 12 leads with interpretation and report | Facility | 2021 | 185 | 190 | $12,217 | $1,216 | 10.0% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 412 | 438 | $576,846 | $61,622 | 10.7% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 170 | 177 | $156,114 | $16,704 | 10.7% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 52 | 53 | $87,132 | $10,136 | 11.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 66 | 69 | $40,779 | $3,337 | 8.2% |
About Dr. Tyler Stephens, D.O
Dr. Tyler Stephens, D.O is a Emergency Medicine healthcare provider based in Oklahoma City, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2014. The National Provider Identifier (NPI) number assigned to this provider is 1811304199.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tyler Stephens, D.O has received a total of $1,145 in payments from pharmaceutical and medical device companies, with $217.66 received in 2024. These payments were reported across 23 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,145).
As a Medicare-enrolled provider, Stephens has provided services to 2,832 Medicare beneficiaries, totaling 2,959 services with total Medicare billing of $303,395. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Location Oklahoma City, OK
- Active Since 07/17/2014
- Last Updated 07/17/2014
- Taxonomy Code 207P00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1811304199
Products in Payments
- ELIQUIS (Drug) $218.28
- XARELTO (Drug) $180.73
- ANDEXXA (Biological) $139.35
- OFIRMEV (Drug) $120.47
- MINOCIN IV (Drug) $115.03
- XIFAXAN (Drug) $109.54
- Kcentra (Biological) $97.76
- BRILINTA (Drug) $87.77
- Veltassa (Drug) $63.25
- Orbactiv (Drug) $12.15
- ORBACTIV (Drug) $1.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Oklahoma City
Alexander Frank, M.d, M.D
Emergency Medicine — Payments: $3.1M
Emergency Medicine $3.1M
Mohammad Razaq, M.d, M.D
Emergency Medicine — Payments: $177,813
Emergency Medicine $177,813
Jose Borrego Acosta, Md, MD
Emergency Medicine — Payments: $76,213
Emergency Medicine $76,213
Lindsey Epperson
Emergency Medicine — Payments: $36,931
Emergency Medicine $36,931
Dr. Tyson Quy, M.d, M.D
Emergency Medicine — Payments: $35,983
Emergency Medicine $35,983
Michael Partin, M.d, M.D
Emergency Medicine — Payments: $10,117
Emergency Medicine $10,117